No Data
No Data
Navigating 5 Analyst Ratings For CareDx
Throughout the last three months, 5 analysts have evaluated CareDx (NASDAQ:CDNA), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, showcasing
Express News | Raymond James Downgrades CareDx to Market Perform
CareDx Cut to Market Perform by Raymond James Over Valuation
Express News | Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $14
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Is Maintained at Overweight by Stephens & Co.
CareDx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 18.42% Stephens & Co. $15 → $18 Maintains Overweight 05/09/2024 -1.32% Craig-Hallum → $15 Reite